{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:14:33Z","timestamp":1777490073547,"version":"3.51.4"},"reference-count":56,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the benefit-risk assessment of atogepant and calcitonin gene\u2013related peptide (CGRP) monoclonal antibodies (mAbs) vs. placebo based on the number needed to treat (NNT) and the number needed to harm (NNH) in a blended episodic migraine and chronic migraine (EM\u2009+\u2009CM) population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The NNT was calculated based on achievement of a \u2265\u200950% reduction in mean monthly migraine days (MMDs) from baseline across 12 weeks. The NNH was calculated using the proportion of participants reporting a discontinuation due to adverse events (AEs). The primary analysis included data from studies of atogepant, erenumab, galcanezumab, eptinezumab and fremanezumab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the primary analysis, the calculated NNT for atogepant 60\u2005mg vs. placebo was 4.2 (95% credible interval (CrI) = 3.1\u20136.7), which was the lowest relative to the CGRP mAbs in the blended EM\u2009+\u2009CM population. Participants who received atogepant 60\u2005mg or fremanezumab showed the most favorable NNH values (\u22121010 (95% Crl = 44 to \u221e to number needed to benefit 80) for atogepant) resulting from lower rates of discontinuation due to AEs compared with those receiving placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Atogepant demonstrated a favorable benefit-risk profile, with NNT and NNH values comparable (not statistically significant) with those of CGRP mAbs across all analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03331024241299377","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T01:51:11Z","timestamp":1731981071000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene\u2013related peptide monoclonal antibodies"],"prefix":"10.1177","volume":"44","author":[{"given":"Jessica","family":"Ailani","sequence":"first","affiliation":[{"name":"MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Lalla","sequence":"additional","affiliation":[{"name":"AbbVie, North Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi B","family":"Halker Singh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagny","family":"Holle-Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, West German Headache and Vertigo Center Essen, University of Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztian","family":"Nagy","sequence":"additional","affiliation":[{"name":"AbbVie, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Kelton","sequence":"additional","affiliation":[{"name":"Medical Decision Modeling Inc., Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2236-8873","authenticated-orcid":false,"given":"Cristiano","family":"Piron","sequence":"additional","affiliation":[{"name":"Medical Decision Modeling Inc., Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8317-7712","authenticated-orcid":false,"given":"Pranav","family":"Gandhi","sequence":"additional","affiliation":[{"name":"AbbVie, North Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4702","authenticated-orcid":false,"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Vall d\u2019Hebron University Hospital, Barcelona, Spain"},{"name":"Headache & Neurological Pain Research Group, Vall d\u2019Hebron Institute of Research, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"bibr1-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"bibr2-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01402-2"},{"key":"bibr3-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000325565.63526.d2"},{"key":"bibr4-03331024241299377","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20100"},{"key":"bibr5-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.13613"},{"key":"bibr6-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280213"},{"key":"bibr7-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00310.x"},{"key":"bibr8-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.13379"},{"key":"bibr9-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0364-19.2019"},{"key":"bibr10-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1137-21.2022"},{"key":"bibr11-03331024241299377","volume-title":"Qulipta [package insert]","year":"2023"},{"key":"bibr12-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70209-1"},{"key":"bibr13-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70128-0"},{"key":"bibr14-03331024241299377","volume-title":"Aimovig [package insert]","year":"2021"},{"key":"bibr15-03331024241299377","volume-title":"Emgality [package insert]","year":"2019"},{"key":"bibr16-03331024241299377","volume-title":"Vyepti [package insert]","year":"2021"},{"key":"bibr17-03331024241299377","volume-title":"Ajovy [package insert]","year":"2021"},{"key":"bibr18-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14692"},{"key":"bibr19-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035908"},{"key":"bibr20-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212"},{"key":"bibr21-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"bibr22-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4853"},{"key":"bibr23-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905132"},{"key":"bibr24-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12142"},{"key":"bibr25-03331024241299377","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15f09870"},{"key":"bibr26-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01049-8"},{"key":"bibr27-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418759786"},{"key":"bibr28-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"bibr29-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418779543"},{"key":"bibr30-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006640"},{"key":"bibr31-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009169"},{"key":"bibr32-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038"},{"key":"bibr33-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30234-9"},{"key":"bibr34-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00249-5"},{"key":"bibr35-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00245-8"},{"key":"bibr36-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00019-3"},{"key":"bibr37-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419858355"},{"key":"bibr38-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01458-0"},{"key":"bibr39-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.13652"},{"key":"bibr40-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14178"},{"key":"bibr41-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14169"},{"key":"bibr42-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/2515816320932573"},{"key":"bibr43-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14138"},{"key":"bibr44-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211024160"},{"key":"bibr45-03331024241299377","volume-title":"NICE DSU technical support document 2: A Generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials","author":"Dias S","year":"2016"},{"key":"bibr46-03331024241299377","volume-title":"NICE DSU technical support document 3: Heterogeneity: Subgroups, meta-regression, bias and bias-adjustment","author":"Dias S","year":"2012"},{"key":"bibr47-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989601"},{"key":"bibr48-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00834-9"},{"key":"bibr49-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0787-1"},{"key":"bibr50-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.13498"},{"key":"bibr51-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14386"},{"key":"bibr52-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14430"},{"key":"bibr53-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"key":"bibr54-03331024241299377","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.1.22"},{"key":"bibr55-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038972"},{"key":"bibr56-03331024241299377","doi-asserted-by":"publisher","DOI":"10.1177\/0333102416678382"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024241299377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03331024241299377","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024241299377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:46:08Z","timestamp":1777387568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03331024241299377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/03331024241299377"],"URL":"https:\/\/doi.org\/10.1177\/03331024241299377","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"article-number":"03331024241299377"}}